News
ReNeuron's latest press releases
ReNeuron signs licence agreement with BioFocus DPI. 26/01/09
Guildford, UK, 26 January 2009: ReNeuron Group plc (LSE: RENE.L) today announces that it has signed a licence with BioFocus DPI, the service division …
Read articleReNeuron clarifies press comments . 21/01/09
Guildford, UK, 21 January 2009: ReNeuron Group plc (LSE: RENE.L) has noted certain comments made in the press following the Company's announcement on …
ReNeuron gains UK regulatory approval to start ground-breaking clinical trial with stem cell therapy for stroke . 19/01/09
Guildford, UK, 19 January 2009: ReNeuron Group plc (LSE: RENE.L) today announces that it has received approval from the UK Medicines and Healthcare …
ReNeuron Group plc Interim Results for the six months ended 30 September 2008. 28/11/08
Guildford UK, 28 November 2008: ReN001 stem cell therapy for stroke - Review of UK clinical trial filing well-advanced - further update to be given …
ReNeuron appoints Bryan Morton as Non-executive Director . 25/11/08
Guildford, UK, 24 November 2008: ReNeuron Group plc (LSE: RENE.L) today announces that it has appointed Bryan Geoffrey Morton as a Non-executive …
ReNeuron to present key safety data at leading European molecular biology scientific conference . 14/11/08
Guildford, UK 14 November 2008: ReNeuron Group plc (LSE: RENE.L) today announces that it will be presenting at the 4th European Molecular Biology …
Results of 2008 Annual General Meeting. 19/09/08
Guildford, UK, 19 September 2008: ReNeuron Group plc (LSE: RENE) announces that all resolutions put to its shareholders at today's 2008 Annual General …
AGM Statement. 19/09/08
Guildford, UK, 19 September 2008: ReNeuron Group plc (LSE: RENE) today announces a business update ahead of its 2008 Annual General Meeting. ReN001 …
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page